Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioventus Inc BVS

Bioventus Inc. is a medical device company. The Company is focused on developing and commercializing clinically differentiated and minimally invasive treatments that engage and enhance the body’s natural healing process. Its portfolio of products is grouped into three areas. Its Pain Treatments include non-surgical pain injection therapies as well as peripheral nerve stimulation (PNS) products to help the patient get back to their normal activities. Its Surgical Solutions include bone graft substitutes (BGS) that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries, as well as a portfolio of ultrasonic products used for precise bone cutting and sculpting, soft tissue management and tissue debridement in various surgeries. Its Restorative Therapies comprise a bone stimulation system, as well as devices designed to help patients regain leg or hand function due to stroke, multiple sclerosis or other central nervous system disorders.


NDAQ:BVS - Post by User

Bullboard Posts
Post by JGrabaron Nov 08, 2023 8:42am
38 Views
Post# 35723175

$BVS Shareholder Suit Survives Motion to Dismiss

$BVS Shareholder Suit Survives Motion to DismissOn 11/23, by order of the U.S. District Court for the Middle District of North Carolina, the Defendants’ motion to dismiss the second amended complaint was denied, and the Plaintiffs Exchange Act claims under § 10(b) and § 20(a) were allowed proceed. $BVS
https://grabarlaw.com/the-latest/bioventus-shareholder-investigation/
Bullboard Posts